http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2509556-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e1c8f52d19c19e2a0bde5443644125c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
filingDate 2012-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf87689a7939a4bb2244b2858a13fb5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c0c5b085649ca29834941a718ec71bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8b46e58fb1adffe1caf9642c230d182
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdab6cc15991166f25288adf3c47178f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17e0517d4286d60d008fd6153ae97e98
publicationDate 2014-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2509556-C2
titleOfInvention Method of treating urethral syndrome in females
abstract FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely medicine, and may be used for treating urethral syndrome in females with using the antibacterial preparation gentamycin. Gentamycin is introduced into a urethral wall in the amount of 80 mg dissolved in anaesthetic solution 2 ml. The above preparation is introduced in parallel with the urethral wall. The anaesthetic is presented by 0.25% Novocaine. That is followed by a vulvar exposure to an infrared laser light at wave length 0.82 mcm, frequency 3000 Hz, and power 10 mWt. A procedure length makes 5-6 minutes; the therapeutic course is 8-10 procedures. n EFFECT: method is well tolerated, accessible and high effective by providing the high gentamycin concentration in the area of inflammation and stimulating repair processes. n 1 ex, 2 tbl, 1 dwg
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2730991-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2559783-C1
priorityDate 2012-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2194537-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2445135-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2360677-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2062453-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2170599-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415850945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146690

Total number of triples: 35.